West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback